¿La Inhibición de la Vía Final Común de la Agregación Plaquetaria Reduce el Fenómeno de no-reflow Durante la Intervención Coronaria Percutánea Primaria? Tirofiban en el Infarto Agudo de Miocardio y la no Reperfusión (TIARA)

14_igor_matos_lago_articulo
Igor Matos Lago, J. Antonio Marin-Neto, Moysés de Oliveira Lima-Filho, Antonio Pazin Filho, Geraldo Luiz Figueiredo, Jorge Luis Haddad, Roberto Botelho, Ricardo Barbosa, Ulisses Marques Gianechini, Breno de Siqueira

More articles by this author

Riesgos de la Radiación X y la Importancia de la Protección Radiológica en la Cardiología Intervencionista: Una Revisión Sistemática

Fernando Leyton, Lucia Canevaro, Adriano Dourado, Helio Castello, Alexandre Bacelar, Marcus Teixeira Navarro, Eliseo Vañó, Maria do Socorro Nogueira, Wilson Otto Batista, Tânia A....

Técnicas y Tácticas en el Tratamiento Endovascular del Aneurisma de la Arteria Renal

Keillyanne Jaira Ferreira Barros, Patrick Bastos Metzger, Fabio Henrique Rossi, Thiago Osawa Rodrigues, Samuel Martins Moreira, Ana Claudia Gomes Petisco, Nilo Mitsuru Izukawa, Antonio...

Cierre Percutáneo de Fístula Aorto-coronaria Venosa Adquirida Luego de Revascularización Miocárdica: Experiencia Inicial con Plug Vascular Auto Expandible de Nitinol

Manuel Pereira Marques Gomes Jr., Ricardo Peressoni Faraco, Manfredo Kenji Naritomi, Elisabeth Tomoko Takitani, José Victor Kairiyama, Cláudia Maria Rodrigues Alves

Denervación Renal con Catéter de Ablación por Radiofrecuencia de Punta Irrigada en Hipertensos Resistentes

Rodolfo Staico, Luciana Armaganijan, Dalmo Moreira, Marcio Sousa, Flavio Borelli, Celso Amodeo, Jônatas Melo Neto, J. Eduardo Sousa, Amanda Sousa, Alexandre Abizaid

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...